Literature DB >> 13340170

The bactericidal activities of antituberculous drugs.

D A MITCHISON, J B SELKON.   

Abstract

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; STREPTOMYCIN/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13340170     DOI： 10.1164/artpd.1956.74.2-2.109

Source DB:  PubMed          Journal:  Am Rev Tuberc        ISSN： 0096-0381


× No keyword cloud information.
  11 in total

1.  CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.

Authors:  D A MITCHISON
Journal:  Br Med J       Date:  1965-05-22

2.  Effect of macrocyclon in acute and chronic pulmonary tuberculous infection in mice as shown by viable and total bacterial counts.

Authors:  P D HART; R J REES
Journal:  Br J Exp Pathol       Date:  1960-08

3.  Effects of isoniazid on the composition of mycobacteria, with particular reference to soluble carbohydrates and related substances.

Authors:  F G Winder; P J Brennan; I McDonnell
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

4.  Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide.

Authors:  Y Hu; J A Mangan; J Dhillon; K M Sole; D A Mitchison; P D Butcher; A R Coates
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 5.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

Review 6.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

7.  Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.

Authors:  C N Paramasivan; S Sulochana; G Kubendiran; P Venkatesan; D A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

8.  Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.

Authors:  Nicholas D Walter; Gregory M Dolganov; Benjamin J Garcia; William Worodria; Alfred Andama; Emmanuel Musisi; Irene Ayakaka; Tran T Van; Martin I Voskuil; Bouke C de Jong; Rebecca M Davidson; Tasha E Fingerlin; Katerina Kechris; Claire Palmer; Payam Nahid; Charles L Daley; Mark Geraci; Laurence Huang; Adithya Cattamanchi; Michael Strong; Gary K Schoolnik; John Lucian Davis
Journal:  J Infect Dis       Date:  2015-03-11       Impact factor: 5.226

9.  Microbial persistence.

Authors:  W McDERMOTT
Journal:  Yale J Biol Med       Date:  1958-02

10.  Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis.

Authors:  Shashikant Srivastava; Chawanga Modongo; Chandima W Siyambalapitiyage Dona; Jotam G Pasipanodya; Devyani Deshpande; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.